Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeuticsAccelerates Ratio's ...

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

Detailed price information for Chemomab Therapeutics Ltd ADR (CMMB-Q) from The Globe and Mail including charting and trades.

BioNTech announces CureVac acquisition for $1.25 billion in stock to strengthen cancer therapy pipeline and mRNA technology ...

Rani Therapeutics Holdings ... a lack of independent advancements or breakthroughs in their own product pipeline. The inclusion of forward-looking statements highlights potential risks and ...

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS ...

Rani Therapeutics’ strategic partnership with Progen Co Limited for the co-development and commercialization of RT-114 is seen as a significant advancement in their pipeline. This partnership aims to ...

Rani Therapeutics is a clinical stage biotech ... and highlight the important advancements that Rani has achieved in its pipeline over the past year. Then I will share how we are leveraging ...

1159 ET – Rani Therapeutics continues to take steps toward what could be a diverse pipeline of oral drugs in obesity, says Maxim Group’s Michael Okunewitch in a research note. The analyst ...